Targets for therapy of the painful bladder

Urology

Volumn 59, Issue 5 SUPPL. 1, 2002, Pages 68-73

  Wein, Alan J ^a   Hanno, Philip M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ARGININE; BCG VACCINE; CIMETIDINE; CYCLOSPORIN; HEPARIN; HYALURONIC ACID; HYDROXYZINE; MISOPROSTOL; MONTELUKAST; NIFEDIPINE; PENTOSAN POLYSULFATE; QUERCETIN;

BLADDER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; HUMAN; INTERSTITIAL CYSTITIS; PAIN; PAINFUL BLADDER SYNDROME; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REMISSION; THEORY; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT FAILURE; UROLOGIC SURGERY;

CYSTITIS, INTERSTITIAL; HUMANS; HYPERSENSITIVITY; MAST CELLS;

EID: 0036234162     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01640-5     Document Type: Conference Paper

References (61)

1. Painful bladder syndromes
2. Interstitial cystitis: Current issues and controversies in diagnosis
3. The epidemiology of interstitial cystitis: Is it time to expand our definition?
4. Interstitial cystitis in Japan
5. Epidemiology of interstitial cystitis
6. Epidemiology of interstitial cystitis
7. Interstitial cystitis in The Netherlands: Prevalence, diagnostic criteria and therapeutic preferences
8. Epidemiology of interstitial cystitis. 2
9. Epidemiology of interstitial cystitis: A population based study
10. Treatments used in women with interstitial cystitis: The interstitial cystitis data base (ICDB) study experience
11. Associations among cystoscopic and urodynamic findings for women enrolled in the Interstitial Cystitis Data Base (ICDB) Study
12. Conservative therapy of interstitial cystitis
13. A function of glycosaminoglycans in the urinary tract
14. Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome
15. An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis
16. Cyto-injury factors in urine: A possible mechanism for the development of interstitial cystitis
17. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis
18. Mast cell involvement in interstitial cystitis: A review of human and experimental evidence
19. Estrogen and neuroinflammation
20. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome
21. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production
22. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis
23. Urine markers of interstitial cystitis
24. Amitriptyline in the treatment of interstitial cystitis
25. Use of amitriptyline in the treatment of interstitial cystitis
26. The use of amitriptyline in patients with urinary frequency and pain
27. The use of dimethyl sulfoxide (DMSO) in the treatment of interstitial cystitis
28. Dimethyl sulfoxide in the treatment of interstitial cystitis
29. A controlled study of dimethyl sulfoxide in interstitial cystitis
30. Standard intravesical therapies for interstitial cystitis
31. Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis: A practical approach
32. Dimethyl sulfoxide does not trigger urine histamine release in interstitial cystitis
33. Pentosan- polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study
34. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate
35. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease
36. Long-term experience with pentosanpolysulfate in interstitial cystitis
37. Hydroxyzine therapy for interstitial cystitis
38. Cimetidine in treatment of interstitial cystitis
39. Treatment of interstitial cystitis with a quercetin supplement
40. Clinical response to an oral prostaglandin analogue in patients with interstitial cystitis
41. Nalmefene in the treatment of interstitial cystitis
42. 4 receptor antagonist
43. Cyclosporine in severe interstitial cystitis
44. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis
45. Effects of L-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis
46. A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis
47. Clinical and immunological response to nifedipine for the treatment of interstitial cystitis
48. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis
49. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis
50. Treatment of interstitial cystitis with intravesical heparin
51. Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid
52. Re: The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: Long-term followup
53. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: A double-blind, prospective, placebo controlled trial
54. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: A prospective, randomized double-blind study
55. Recombinant human nerve growth factor in the treatment of interstitial cystitis: Preliminary results
56. Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis
57. Sacral nerve stimulation in patients with chronic, intractable pelvic pain
58. Surgical management of interstitial cystitis
59. Laser therapy for interstitial cystitis
60. Use of the neodymium:YAG laser for interstitial cystitis: A prospective study